Document Detail


The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women.
MedLine Citation:
PMID:  19588379     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Bacterial vaginosis (BV) is a very common cause of vaginitis that has been associated with a high incidence of obstetric and gynaecologic complications and increased risk of HIV-1 transmission. This has led to renewed research interest in its treatment.
OBJECTIVES: To assess the effects of antimicrobial agents on BV in non-pregnant women.
SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE, EMBASE, LILACS, and African Healthline (December 2007); and proceedings of relevant international conferences (from 1981 to date).
SELECTION CRITERIA: Randomised controlled trials comparing any two or more antimicrobial agents, or antimicrobial agents with placebo or no treatment, in women with clinical or Gram-stain criteria of BV.
DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data from the original publications while the third author cross checked the data.
MAIN RESULTS: Twenty-four trials involving 4422 participants were reviewed. Most examined symptomatic women only. Only seven trials analysed results by intention to treat; we re-analysed the remainder.Compared with placebo, clindamycin showed a lower rate of treatment failure (relative risk (RR) 0.25, 95% confidence interval (CI) 0.16 to 0.37). Clindamycin and metronidazole showed identical rates of treatment failure, irrespective of regimen type, at two and four-week follow up (RR 1.01, 95% CI 0.69 to 1.46; RR 0.91, 95% CI 0.70 to 1.18, respectively). Clindamycin tended to cause a lower rate of adverse events (RR 0.75, 95% CI 0.56 to 1.02); metallic taste, and nausea and vomiting were more common in the metronidazole group (RR 0.08, 95% CI 0.1 to 0.59; RR 0.23, 95% CI 0.10 to 0.51, respectively). Given intravaginally as gelatin tablets, lactobacillus was more effective than oral metronidazole (RR 0.20, 95% CI 0.05 to 0.08). Similarly, oral lactobacillus combined with metronidazole was more effective than metronidazole alone (RR 0.33, 95% CI 0.14 to 0.77). Clindamycin showed a lower rate of clinical failure than triple sulfonamide cream (RR 0.46, 95% CI 0.29 to 0.72). Hydrogen peroxide douche showed a higher rate of clinical failure (RR 1.75, 95% CI 1.02 to 3.00) and adverse events (RR 2.33, 95% CI 1.21 to 4.52) than a single 2 g dose of metronidazole.
AUTHORS' CONCLUSIONS: Clindamycin preparations, oral metronidazole, and oral and intravaginal tablets of lactobacillus were effective for bacterial vaginosis. Hydrogen peroxide douche and triple sulphonamide cream were ineffective. Metronidazole caused metallic taste, nausea and vomiting. We need better-designed trials with larger sample sizes to test the effectiveness of promising drugs.
Authors:
Oyinlola O Oduyebo; Rose I Anorlu; Folasade T Ogunsola
Related Documents :
18072169 - Valsartan ingestions among adults reported to texas poison control centers, 2000 to 2005.
20860989 - Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a sys...
16043669 - Mortality in us army gulf war veterans exposed to 1991 khamisiyah chemical munitions de...
25185629 - Pelvic organ prolapse: a disease of silence and shame.
20131329 - Obstetric morbidity associated with amniotic sheets.
16246989 - Anemia and outcomes in patients with heart failure: a study from the national heart car...
9134239 - Tobacco and non-hodgkin's lymphoma: combined analysis of three case-control studies (un...
24321849 - Mutagenicity of smoke condensates from canadian cigarettes with different design features.
19349479 - A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severi...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2009-07-08
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2009  
Date Detail:
Created Date:  2009-07-09     Completed Date:  2009-08-14     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD006055     Citation Subset:  IM    
Affiliation:
Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, F Block, Lagos, Nigeria, PMB 12003.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents / adverse effects,  therapeutic use
Clindamycin / adverse effects,  therapeutic use
Female
Humans
Lactobacillus
Metronidazole / adverse effects,  therapeutic use
Probiotics / therapeutic use
Randomized Controlled Trials as Topic
Vaginal Douching / adverse effects
Vaginosis, Bacterial / therapy*
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 18323-44-9/Clindamycin; 443-48-1/Metronidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Family support for reducing morbidity and mortality in people with HIV/AIDS.
Next Document:  Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surg...